Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Sahm

Showing results (291-300 of 451) with videos related to

Pageof 46
Sort By:
Journal of Neuro-Oncology|February 22, 2022
Clinical and molecular characterization of isolated M1 disease in pediatric medulloblastoma: experience from the German HIT-MED studiesDenise Obrecht, Martin Mynarek, Christian Hagel, et al.
Acta Neuropathologica|March 24, 2017
Identification of T cell target antigens in glioblastoma stem-like cells using an integrated proteomics-based approach in patient specimensCarmen Rapp, Rolf Warta, Slava Stamova, et al.
Science Immunology|May 3, 2024
The immunoglobulin superfamily ligand B7H6 subjects T cell responses to NK cell surveillanceMichael Kilian, Mirco J Friedrich, Kevin Hai-Ning Lu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2024
Incorporating Supramaximal Resection into Survival Stratification of IDH-wildtype Glioblastoma: A Refined Multi-institutional Recursive Partitioning AnalysisYae Won Park, Kyu Sung Choi, Martha Foltyn-Dumitru, et al.
Cell Genomics|May 24, 2024
Meningioma transcriptomic landscape demonstrates novel subtypes with regional associated biology and patient outcomeH Nayanga Thirimanne, Damian Almiron-Bonnin, Nicholas Nuechterlein, et al.
Journal of Neurointerventional Surgery|August 1, 2023
MR microscopy to assess clot composition following mechanical thrombectomy predicts recanalization and clinical outcomeKianush Karimian-Jazi, Dominik F Vollherbst, Daniel Schwarz, et al.
Neuro-Oncology|March 5, 2026
Spatial Transcriptomics Characterisation of Radionecrotic Changes in Glioblastoma PatientsZaira Seferbekova, Michael Ritter, Gleb Ruckhovich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2019
Germline <i>GPR161</i> Mutations Predispose to Pediatric MedulloblastomaMatthias Begemann, Sebastian M Waszak, Giles W Robinson, et al.
The American Journal of Surgical Pathology|April 21, 2022
SMARCB1-deficient and SMARCA4-deficient Malignant Brain Tumors With Complex Copy Number Alterations and TP53 Mutations May Represent the First Clinical Manifestation of Li-Fraumeni SyndromeMartin Hasselblatt, Christian Thomas, Aniello Federico, et al.
Brain Pathology (Zurich, Switzerland)|July 27, 2021
An integrative histopathological and epigenetic characterization of primary intracranial mesenchymal tumors, FET:CREB-fused broadening the spectrum of tumor entities in comparison with their soft tissue counterpartsArnault Tauziède-Espariat, Philipp Sievers, Frédérique Larousserie, et al.
Pageof 46

Showing results (291-300 of 451) with videos related to

Sort By:
Pageof 46
Journal of Neuro-Oncology|February 22, 2022
Clinical and molecular characterization of isolated M1 disease in pediatric medulloblastoma: experience from the German HIT-MED studiesDenise Obrecht, Martin Mynarek, Christian Hagel, et al.
Acta Neuropathologica|March 24, 2017
Identification of T cell target antigens in glioblastoma stem-like cells using an integrated proteomics-based approach in patient specimensCarmen Rapp, Rolf Warta, Slava Stamova, et al.
Science Immunology|May 3, 2024
The immunoglobulin superfamily ligand B7H6 subjects T cell responses to NK cell surveillanceMichael Kilian, Mirco J Friedrich, Kevin Hai-Ning Lu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2024
Incorporating Supramaximal Resection into Survival Stratification of IDH-wildtype Glioblastoma: A Refined Multi-institutional Recursive Partitioning AnalysisYae Won Park, Kyu Sung Choi, Martha Foltyn-Dumitru, et al.
Cell Genomics|May 24, 2024
Meningioma transcriptomic landscape demonstrates novel subtypes with regional associated biology and patient outcomeH Nayanga Thirimanne, Damian Almiron-Bonnin, Nicholas Nuechterlein, et al.
Journal of Neurointerventional Surgery|August 1, 2023
MR microscopy to assess clot composition following mechanical thrombectomy predicts recanalization and clinical outcomeKianush Karimian-Jazi, Dominik F Vollherbst, Daniel Schwarz, et al.
Neuro-Oncology|March 5, 2026
Spatial Transcriptomics Characterisation of Radionecrotic Changes in Glioblastoma PatientsZaira Seferbekova, Michael Ritter, Gleb Ruckhovich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2019
Germline <i>GPR161</i> Mutations Predispose to Pediatric MedulloblastomaMatthias Begemann, Sebastian M Waszak, Giles W Robinson, et al.
The American Journal of Surgical Pathology|April 21, 2022
SMARCB1-deficient and SMARCA4-deficient Malignant Brain Tumors With Complex Copy Number Alterations and TP53 Mutations May Represent the First Clinical Manifestation of Li-Fraumeni SyndromeMartin Hasselblatt, Christian Thomas, Aniello Federico, et al.
Brain Pathology (Zurich, Switzerland)|July 27, 2021
An integrative histopathological and epigenetic characterization of primary intracranial mesenchymal tumors, FET:CREB-fused broadening the spectrum of tumor entities in comparison with their soft tissue counterpartsArnault Tauziède-Espariat, Philipp Sievers, Frédérique Larousserie, et al.
Pageof 46